Evidence map›Paper›PMID 40074350›Full record

ArticleCell structure and function2025

Chemokine induces phase transition from non-directional to directional migration during angiogenesis.

Ning Gui, Keisuke Sako, Moe Fukumoto, Naoki Mochizuki, Hiroyuki Nakajima

Abstract read
In one paragraph

Article in Cell structure and function, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ning GuiDepartment of Cell Biology, National Cerebral and Cardiovascular Center Research Institute.
Keisuke SakoDepartment of Cell Biology, National Cerebral and Cardiovascular Center Research Institute.
Moe FukumotoDepartment of Cell Biology, National Cerebral and Cardiovascular Center Research Institute.
Naoki MochizukiDepartment of Cell Biology, National Cerebral and Cardiovascular Center Research Institute.
Hiroyuki NakajimaDepartment of Cell Biology, National Cerebral and Cardiovascular Center Research Institute.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During angiogenesis, sprouting endothelial cells (ECs) migrate and eventually connect to target vessels to form new vessel branches. However, it remains unclear how these sprouting vessels migrate toward the target vessels in three-dimensional space. We performed in vivo imaging of the cerebral capillary network formation in zebrafish to investigate how sprouting tip cells migrate toward their targets. Of note, we found that tip cells reach the target vessels through two phases: a non-directional phase and a directional phase. In the non-directional phase, sprouting tip cells dynamically extend and retract their protrusions at the leading front and have less directionality in their movement. In contrast, once tip cells enter the directional phase, they migrate directly toward the anastomotic targets. Chemokine receptor Cxcr4a and its ligand Cxcl12b are important for the phase transition to the directional phase. In cxcr4a mutants, sprouting tip cells lose their directionality and tend to connect to nearby sprouting ECs, resulting in altered capillary network patterning. Furthermore, in wild-type (WT) larvae, local Ca

Indexed as

Cell MovementChemokine CXCL12Neovascularization, PhysiologicZebrafish ProteinsAngiogenesisAnimalsEndothelial CellsReceptors, CXCR4ZebrafishChemokine CXCL12CXCR4a protein, zebrafishReceptors, CXCR4Zebrafish ProteinsangiogenesisCa2+ dynamicschemokinedirectional migrationlive imagingzebrafish

Identifiers

PMID40074350
PMCPMC12702683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.